Datopotamab deruxtecan: Data from P2 TROPION-PanTumor03 trial (NCT05489211) for advanced solid tumors post 2025 (AstraZeneca) - Nov 12, 2024 - Q3 2024 Results: Data from P1 TROPION-PanTumor01 trial (NCT03401385) for solid tumors in H2 2025
P1 data • P2 data • Oncology • Solid Tumor
|